R. Charco

Publications243
h-index30
Citations3,078
Highly Influential Citations110
Claim Author Page
Author pages are created from data sourced from our academic publisher partnerships and public sources.

Recommended Authors

  • M. Berenguer
  • 174 Publications, 6,268 Citations
  • J. Bruix
  • 582 Publications, 75,073 Citations
  • D. Samuel
  • 771 Publications, 26,542 Citations
  • R. Busuttil
  • 988 Publications, 40,432 Citations
  • Publications
  • Influence
Liver Transplant Using Donors After Unexpected Cardiac Death: Novel Preservation Protocol and Acceptance Criteria
Donors after cardiac death (DCD) suffer irreversible cardiac arrest prior to donation. We describe our liver transplant experience with DCD whose cardiac arrest is unexpected, not following the… Expand
  • 254
  • 14
Risk factors for acute renal failure requiring dialysis after liver transplantation.
Acute renal failure (ARF) is a common and severe complication after liver transplantation (LT). The aim of this study was to ascertain the impact of ARF requiring dialysis in the outcome of LT and to… Expand
  • 172
  • 7
Intrahepatic Cholangiocarcinoma or Mixed Hepatocellular-Cholangiocarcinoma in Patients Undergoing Liver Transplantation: A Spanish Matched Cohort Multicenter Study
Objective:To evaluate the outcome of patients with hepatocellular-cholangiocarcinoma (HCC-CC) or intrahepatic cholangiocarcinoma (I-CC) on pathological examination after liver transplantation for… Expand
  • 82
  • 7
Ischemic Pre‐conditioning in Deceased Donor Liver Transplantation: A Prospective Randomized Clinical Trial
To assess the immediate and long‐term effects of ischemic preconditioning (IPC) in deceased donor. liver transplantation (LT), we designed a prospective, randomized controlled trial involving 60… Expand
  • 102
  • 5
Portal vein thrombosis in liver transplantation.
In the initial experience of liver transplantation, complete thrombosis and portal vein occlusion were considered to be absolute contraindications for liver transplantation. The incidence of portal… Expand
  • 73
  • 4
Hepatic Resection for Liver Metastases as Part of the “Oncosurgical” Treatment of Metastatic Breast Cancer
BackgroundMetastatic breast cancer is considered an incurable disease despite new therapies. Recent studies suggest that liver resection associated with systemic treatment may improve patient… Expand
  • 71
  • 4
Single HCC in Cirrhotic Patients: Liver Resection or Liver Transplantation? Long-term Outcome According to an Intention-to-treat Basis
ABSTRACTBackgroundCompensated cirrhotic patients with single hepatocellular carcinoma (HCC) ≤5 cm may benefit from both liver resection (LR) and liver transplantation (LT); however, the better… Expand
  • 72
  • 4
A Personalized Preclinical Model to Evaluate the Metastatic Potential of Patient-Derived Colon Cancer Initiating Cells
Purpose: Within the aim of advancing precision oncology, we have generated a collection of patient-derived xenografts (PDX) characterized at the molecular level, and a preclinical model of colon… Expand
  • 58
  • 4
  • PDF
Tankyrase Inhibition Blocks Wnt/β-Catenin Pathway and Reverts Resistance to PI3K and AKT Inhibitors in the Treatment of Colorectal Cancer
Purpose: Oncogenic mutations in the KRAS/PI3K/AKT pathway are one of the most frequent alterations in cancer. Although PI3K or AKT inhibitors show promising results in clinical trials, drug… Expand
  • 91
  • 3
  • PDF
Clinical trial on the cost‐effectiveness of T‐tube use in an established deceased donor liver transplantation program
Abstract:  The aim of our study was to assess the advantages and disadvantages of T‐tube use in liver transplantation, with also paying attention to the economic costs derived from its use. Patients… Expand
  • 32
  • 3